Retrospective study of clinical profile and management of patients with swine flu at tertiary care hospital
Keywords:Corticosteroids, Mortality, Swine flu
Background: The first isolation of a swine influenza virus from a human occurred in 1974. There are no unique clinical features that distinguish swine influenza in humans from typical influenza. Thus, clinical course and management were recorded as per a planned pro forma and analysed. This type of study has not been done previously in Himalayan region.
Methods: Retrospective observational study done in a group of patients diagnosed with swine flu admitted in department of pulmonary medicine at the tertiary care hospital from November 2016 to July 2017.
Results: Out of 30 patients, 53.3% were male, mean age was 48.8±17.7, history of travel or contact to infected person was only 13.3%. Most common symptom recorded was fever (83.3%), followed by dyspnoea, cough, throat pain. Most common co-morbidity was diabetes and presence were significantly associated with admission in an ICU (P<0.05). Bilateral lung infiltrate seen in 53.3% on chest X-ray. Organ involved other than respiratory were renal followed by liver involvement. 40% of patients received corticosteroid for an average of 6days, mostly given in patients with sepsis, septic shock, multi organ involvement. Out of 40%, 16.6% patient expired, 6.6% left against medical advice and 16.6% were discharged, corticosteroid doesn’t help in reducing mortality.
Conclusions: A multivariate model to identify independent predictors associated with mortality in swine flu were the use of vasopressor, respiratory failure, requirement of mechanical ventilation and number of organ failure. Use of corticosteroid is controversial.
Myers KP, Olsen CW, Gray GC. Cases of swine influenza in humans: a review of the literature. Clin Infectious Dis. 2007;44(8):1084-8.
Shope RE. Swine influenza: I. Experimental transmission and pathology. J Experimental Med. 1931;54(3):349-59.
Smith TF, Burgert Jr EO, Dowdle WR, Noble GR, Campbell RJ, Van Scoy RE. Isolation of swine influenza virus from autopsy lung tissue of man. New Eng J Med. 1976;294(13):708-10.
Ito T, Couceiro JN, Kelm S, Baum LG, Krauss S, Castrucci MR, et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol. 1998;72(9):7367-73.
Park K, eds. Park's Textbook of Preventive and Social Medicine. 23rd ed. Jabalpur: Banarsidas Bhanot; 2015.
Shrikhande S, Bhoyar SK, Tenpe SH, Deogade NG. Epidemiology of pandemic H1N1 strains in a tertiary hospital of Maharashtra. Ind J Public Health. 2012;56(3):242.
Amaravathi KS, Sakuntala P, Sudarsi B, Manohar S, Nagamani R, Rao SR. Clinical profile and outcome of recent outbreak of influenza A H1N1 (swine flu) at a tertiary care center in Hyderabad, Telangana. Ann Trop Med Pub Heal. 2015;8(6):267-71.
Mehta AA, Kumar VA, Nair SG, Joseph FK, Kumar G, Singh SK. Clinical profile of patients admitted with swine-origin influenza A (H1N1) virus infection: an experience from a tertiary care hospital. JCDR. 2013;7(10):2227-30.
Chudasama RK, Patel UV, Verma PB, Amin CD, Savaria D, Ninama R, et al. Clinico-epidemiological features of the hospitalized patients with 2009 pandemic influenza A (H1N1) virus infection in Saurashtra region, India (September 2009 to February 2010). Lung India: official organ Ind Chest Soc. 2011;28(1):11.
Sardar JC, Sau A, Mandal PK. Clinico-epidemiological profile of confirmed swine flu (H1N1) cases admitted at an infectious disease hospital in Kolkata, India. Inter J Community Med Public Health. 2017;3(8):2340-3.
Abramowitz LJ. The effect of Asian influenza on pregnancy. South Afr Med J. 1958;32(48):1155-6.
Beigi RH. Pandemic influenza and pregnancy: a call for preparedness planning. Obs Gynecol. 2007;109(5):1193-6.
Dodds L, McNeil SA, Fell DB, Allen VM, Coombs A, Scott J, et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. Can Med Assoc J. 2007;176(4):463-8.
George HJ, Ameer KA, Nair K, Arjun P, Kesavan VK, Varghese A. The clinical profile of H1N1 patients. Lung India. 2015 Nov;32(Suppl2):S43-S81.
Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. New Eng J Med. 2009;361(20):1935-44.
Chien YS, Su CP, Tsai HT, Huang AS, Lien CE, Hung MN, et al. Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan. J Infection. 2010;60(2):168-74.
Auyeung TW, Lee JS, Lai WK, Choi CH, Lee HK, Lee JS, et al. The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study. J Infection. 2005;51(2):98-102.
Shlomai A, Nutman A, Kotlovsky T, Schechner V, Carmeli Y, Guzner-Gur H. Predictors of pandemic (H1N1) 2009 virus positivity and adverse outcomes among hospitalized patients with a compatible syndrome. IMAJ-Israel Med Assoc J. 2010;12(10):622-7.
Liem NT, Tung CV, Hien ND, Hien TT, Chau NQ, Long HT, et al. Clinical features of human influenza A (H5N1) infection in Vietnam: 2004–2006. Clin Infectious Dis. 2009;48(12):1639-46.
WHO Guidelines for Pharmacological Management of Pandemic Influenza A (H1N1) and Other Influenza Viruses, 2009. Geneva: World Health Organization; 2010.